Description
This product combines two growth-hormone-axis research peptides in a single vial: CJC-1295 (a GHRH analog, No DAC variant) and Ipamorelin (a selective growth hormone secretagogue). Both compounds are characterized in the research literature for studies in somatotropic-axis research and pituitary-function research. Nova supplies the blend as 5mg CJC-1295 + 5mg Ipamorelin lyophilized in a single vial, requiring reconstitution with a suitable solvent before research use. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory. Every vial ships with a QR code linked to its batch Certificate of Analysis. For research use only. Not for human or animal consumption.











Reviews
There are no reviews yet.